These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21390054)

  • 1. The effect of antihypertensive agents in people at high risk of cardiovascular disease and diabetes: a view through smoke and mirrors.
    McInnes GT
    J Hum Hypertens; 2011 Jun; 25(6):343-5. PubMed ID: 21390054
    [No Abstract]   [Full Text] [Related]  

  • 2. The 'pyrrhic victory' of amlodipine over hydrochlorothiazide in the OLAS Study.
    Thomopoulos C; Tsioufis C; Makris T; Stefanadis C
    J Hum Hypertens; 2011 Jun; 25(6):401-2; author reply 403-4. PubMed ID: 21368776
    [No Abstract]   [Full Text] [Related]  

  • 3. If I had resistant hypertension.
    O'Brien E
    Hypertension; 2014 Nov; 64(5):e3-6. PubMed ID: 25113965
    [No Abstract]   [Full Text] [Related]  

  • 4. Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study.
    Martinez-Martin FJ; Rodriguez-Rosas H; Peiro-Martinez I; Soriano-Perera P; Pedrianes-Martin P; Comi-Diaz C
    J Hum Hypertens; 2011 Jun; 25(6):346-53. PubMed ID: 21107432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tribenzor for hypertension.
    Med Lett Drugs Ther; 2010 Sep; 52(1346):70-1. PubMed ID: 20814402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide triple combination for hypertension.
    Ram CV
    Expert Rev Cardiovasc Ther; 2011 Jan; 9(1):9-19. PubMed ID: 21166525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Optimizing antihypertensive therapy].
    Schlimpert V
    MMW Fortschr Med; 2015 Feb; 157(3):66. PubMed ID: 25743673
    [No Abstract]   [Full Text] [Related]  

  • 8. Olmesartan/amlodipine: blood pressure lowering and beyond in special populations.
    Erdine S
    Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):31-44. PubMed ID: 22222315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
    Oparil S; Chrysant SG; Melino M; Lee J; Karki S; Heyrman R
    J Hum Hypertens; 2010 Dec; 24(12):831-8. PubMed ID: 20200547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice.
    Bramlage P; Fronk EM; Wolf WP; Smolnik R; Sutton G; Schmieder RE
    Vasc Health Risk Manag; 2015; 11():1-8. PubMed ID: 25565857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertension. Guidelines recommend fixed combinations].
    MMW Fortschr Med; 2014 Apr; 156(7):62-3. PubMed ID: 24956662
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study).
    Nesbitt SD; Shojaee A; Maa JF; Weir MR
    J Hum Hypertens; 2013 Jul; 27(7):445-52. PubMed ID: 23254596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of olmesartan medoxomil plus amlodipine in age, gender and hypertension severity defined subgroups of hypertensive patients.
    Schmieder RE; Böhm M
    J Hum Hypertens; 2011 Jun; 25(6):354-63. PubMed ID: 20686499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients.
    Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
    Clin Exp Hypertens; 2013; 35(5):301-7. PubMed ID: 22954201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of up-titration of candesartan versus candesartan plus amlodipine on kidney function in type 2 diabetic patients with albuminuria.
    Okura T; Kojima M; Machida H; Sugiyama M; Kato T; Komada T; Miyazaki T; Ninomiya T; Ichikawa T; Nakatani K; Watanabe Y; Dohi Y; Ito M; Kimura G
    J Hum Hypertens; 2012 Apr; 26(4):214-9. PubMed ID: 21412266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension.
    Barrios V; Escobar C
    Expert Opin Pharmacother; 2008 Jan; 9(1):129-36. PubMed ID: 18076344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple fixed-dose combination therapy: back to the past.
    Black HR
    Hypertension; 2009 Jul; 54(1):19-22. PubMed ID: 19470871
    [No Abstract]   [Full Text] [Related]  

  • 19. VALUE study highlights the need for aggressive BP lowering in high-risk patients.
    Cardiovasc J S Afr; 2004; 15(4):191-2, 195. PubMed ID: 15322578
    [No Abstract]   [Full Text] [Related]  

  • 20. Olmesartan-based therapies: an effective way to improve blood pressure control and cardiovascular protection.
    de la Sierra A; Volpe M
    J Hypertens; 2013 Mar; 31 Suppl 1():S13-7. PubMed ID: 23389083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.